text
"['\n4. 매출 및 수주상황\n가. 매출실적\n\xa0 \xa0 \xa0 ( 단위 : 백만원 )\n구분\n사업부문\n품목\n구분\n제52기 1분기\n제51 기\n제50 기\n계속영업사업\n산업설비공사\n산업설비플랜트E.P.C\n수출\n-\n1,181\n1,723\n내수\n25,745\n70,505\n70,098\n합계\n25,745\n71,686\n71,821\n화장품\n노보스트라타 등\n수출\n-\n-\n-\n내수\n8\n402\n649\n합계\n8\n402\n649\n건강식품\n스위치온 등\n수출\n-\n-\n-\n내수\n234\n1,253\n-\n합계\n234\n1,253\n-\n셀론텍\n리젠씰, 카티졸 등\n수출\n-\n-\n-\n내수\n2,668\n2,345\n-\n합계\n2,668\n2,345\n-\n기타\n젠바디 등\n수출\n-\n-\n-\n내수\n65\n39\n-\n합계\n65\n39\n-\n소계\n수출\n-\n1,181\n1,723\n내수\n28,720\n74,544\n70,747\n합계\n28,720\n75,725\n72,470\n중단영업사업\n세원이앤씨_PE\n열교환기, 반응기 등\n수출\n-\n-\n42,401\n내수\n-\n-\n8,722\n합계\n-\n-\n51,123\n세원이앤씨_PL\nVALVE 등\n수출\n-\n-\n10\n내수\n-\n-\n2,713\n합계\n-\n-\n2,723\n세원이앤씨_RMS\n세포치료제, 가족제대혈은행\n수출\n-\n-\n163\n내수\n-\n-\n12,216\n합계\n-\n-\n12,379\n상해세원액압유한공사\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n-\n179\n합계\n-\n-\n179\n셀론텍\n콘드론, 오스론, 베이비셀\n수출\n-\n-\n내수\n216\n147\n합계\n216\n147\n소계\n수출\n-\n-\n42,574\n내수\n216\n147\n23,830\n합계\n216\n147\n66,404\n나. 수주상황\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n기초\n증감액\n공사수익인식\n기말\n산업설비공사\n87,552,597\n35,709,313\n25,745,260\n97,516,650\n다.\xa0진행율 적용 수주 현황\n(단위: 천원)\n계약처\n계약일자\n계약상완성기한\n진행율\n수주총액\n계약자산\n매출채권\n총액\n손상차손누계액\n총액\n대손충당금\n머크버슘머트리얼즈코리아㈜\n20/12/02\n22/04/30\n100%\n7,185,000\n-\n-\n49,500\n-\n노루홀딩스\n21/03/29\n22/03/31\n100%\n3,975,313\n-\n-\n-\n-\n금호피앤비화학㈜\n21/03/23\n22/04/30\n100%\n7,680,000\n-\n-\n-\n-\n스미세이케미칼㈜\n21/04/01\n22/05/31\n89%\n15,570,000\n1,282,646\n-\n3,288,979\n-\n한화솔루션\n21/04/06\n22/09/30\n49%\n32,720,069\n-\n-\n2,798,405\n-\n금호미쓰이화학㈜\n21/06/29\n22/12/31\n40%\n29,910,000\n-\n-\n1,124,838\n-\n삼양이노켐㈜\n21/08/18\n22/04/30\n100%\n6,540,000\n-\n-\n-\n-\n티이엠씨 주식회사\n21/11/16\n22/07/30\n23%\n6,230,000\n-\n-\n-\n-\n금호석유화학(주)여수정밀화학\n21/12/17\n23/06/30\n5%\n22,440,000\n-\n-\n-\n-\n금호미쓰이화학㈜\n22/03/02\n22/08/31\n17%\n4,410,000\n306,054\n-\n485,100\n-\n에스케이 트리켐 주식회사\n22/03/21\n23/02/15\n1%\n29,450,000\n-\n-\n3,239,500\n-\n']"
